Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Insulin9623 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A52946 | 19148125 | Obesity (Silver Spring) | Prevention and reversal of obesity and glucose intolerance in mice by DHA derivatives. | 2009 | Details |
| A52947 | 19129712 | Horm Res | Triglycerides and alanine aminotransferase as screening markers for suspected fatty liver disease in obese children and adolescents. | 2009 | Details |
| A52948 | 20300478 | PPAR Res | PPAR/RXR Regulation of Fatty Acid Metabolism and Fatty Acid omega-Hydroxylase (CYP4) Isozymes: Implications for Prevention of Lipotoxicity in Fatty Liver Disease. | 2010 | Details |
| A52950 | 19053047 | Hepatology | Differential effects of JNK1 and JNK2 inhibition on murine steatohepatitis and insulin resistance. | 2009 | Details |
| A52951 | 19046738 | Clin Cornerstone | Endocrine functions of adipose tissue: focus on adiponectin. | 2008 | Details |
| A52954 | 18946208 | Ann Nutr Metab | Serum leptin as a predictor of fatty liver in 7-year-old Korean children. | 2008 | Details |
| A52958 | 18846047 | Obesity (Silver Spring) | Obesity upregulates genes involved in oxidative phosphorylation in livers of diabetic patients. | 2008 | Details |
| A52961 | 18773755 | G Ital Cardiol (Rome) | [Pharmacological therapy of obesity]. | 2008 | Details |
| A52964 | 18716169 | J Nutr | The major green tea polyphenol, (-)-epigallocatechin-3-gallate, inhibits obesity, metabolic syndrome, and fatty liver disease in high-fat-fed mice. | 2008 | Details |
| A52969 | 18633113 | Diabetes | Plasma fetuin-A levels and the risk of type 2 diabetes. | 2008 | Details |
| A52970 | 18630061 | Rev Med Suisse | [Metabolic syndrome, a mitochondrial disease?]. | 2008 | Details |
| A52971 | 18619057 | Gac Med Mex | [Obesity, inflammation and diabetes]. | 2008 | Details |
| A52972 | 18596860 | Trans Am Clin Climatol Assoc | Fatty liver and insulin resistance: not always linked. | 2008 | Details |
| A52974 | 18524748 | Arch Pediatr Adolesc Med | Body mass index, waist circumference, and chronic disease risk factors in Australian adolescents. | 2008 | Details |
| A52975 | 18497882 | J Clin Invest | Overindulgence and metabolic syndrome: is FoxO1 a missing link? | 2008 | Details |
| A52978 | 18446001 | Endocr J | Molecular mechanism of moderate insulin resistance in adiponectin-knockout mice. | 2008 | Details |
| A52979 | 18445783 | J Pharmacol Exp Ther | Age-dependent development of metabolic derangement and effects of intervention with pioglitazone in Zucker diabetic fatty rats. | 2008 | Details |
| A52980 | 18436717 | Clin Chem | The perfect storm: obesity, adipocyte dysfunction, and metabolic consequences. | 2008 | Details |
| A52982 | 18366118 | Hepatology | Steatohepatitis: Risk factors and impact on disease severity in human immunodeficiency virus/hepatitis C virus coinfection. | 2008 | Details |
| A52983 | 18335040 | PLoS One | Fetuin-A induces cytokine expression and suppresses adiponectin production. | 2008 | Details |
| A52987 | 18230901 | Front Horm Res | 11beta-hydroxysteroid dehydrogenase type 1 and obesity. | 2008 | Details |
| A52989 | 18220945 | Endocr Metab Immune Disord Drug Targets | Does global gene expression analysis in type 2 diabetes provide an opportunity to identify highly promising drug targets? | 2007 | Details |
| A52990 | 18220654 | Curr Diabetes Rev | Peroxisome proliferator-activated receptor (PPAR) in metabolic syndrome and type 2 diabetes mellitus. | 2007 | Details |
| A52991 | 18185059 | Curr Opin Endocrinol Diabetes Obes | Metabolic complications of obesity in childhood and adolescence: more than just diabetes. | 2008 | Details |
| A52994 | 18171433 | Acta Physiol (Oxf) | RNAi screens reveal novel metabolic regulators: RIP140, MAP4k4 and the lipid droplet associated fat specific protein (FSP) 27. | 2008 | Details |
| A52995 | 18164296 | Gastroenterology | Insulin resistance in chronic hepatitis C: association with genotypes 1 and 4, serum HCV RNA level, and liver fibrosis. | 2007 | Details |
| A52997 | 18154189 | Clin Cornerstone | Metabolic consequences of hyperglycemia and insulin resistance. | 2007 | Details |
| A53001 | 17933490 | Genomics | Gene expression profiling in livers of mice after acute inhibition of beta-oxidation. | 2007 | Details |
| A53002 | 17925761 | Gastroenterol Clin Biol | [Steatosis during chronic hepatitis C: the role of insulin resistance and viral factors]. | 2008 | Details |
| A53003 | 17785696 | Eur J Endocrinol | Fat distribution and storage: how much, where, and how? | 2007 | Details |
| A53005 | 17901224 | Endocrinology | Obesity-induced inflammation in white adipose tissue is attenuated by loss of melanocortin-3 receptor signaling. | 2007 | Details |
| A53006 | 17855068 | J Nutr Biochem | Oxidative stress-induced risk factors associated with the metabolic syndrome: a unifying hypothesis. | 2007 | Details |
| A53007 | 17721396 | J Acquir Immune Defic Syndr | Magnetic resonance spectroscopy of hepatic lipid content and associated risk factors in HIV infection. | 2007 | Details |
| A53008 | 17664243 | Diabetes | FGFR4 prevents hyperlipidemia and insulin resistance but underlies high-fat diet induced fatty liver. | 2007 | Details |
| A53009 | 17611153 | Heart Lung Circ | The clinical biochemistry of obesity-more than skin deep. | 2007 | Details |
| A53015 | 17400720 | Am J Physiol Heart Circ Physiol | Impairment of cardiac insulin signaling and myocardial contractile performance in high-cholesterol/fructose-fed rats. | 2007 | Details |
| A53017 | 17320517 | Am J Med | Effect of insulin resistance, dyslipidemia, and intra-abdominal adiposity on the development of cardiovascular disease and diabetes mellitus. | 2007 | Details |
| A53018 | 17296343 | Am J Med | Abdominal obesity: role in the pathophysiology of metabolic disease and cardiovascular risk. | 2007 | Details |
| A53021 | 17259477 | Diabetes Care | High circulating retinol-binding protein 4 is associated with elevated liver fat but not with total, subcutaneous, visceral, or intramyocellular fat in humans. | 2007 | Details |
| A53024 | 17164113 | Clin Liver Dis | The changing epidemiology and natural history of hepatitis C virus infection. | 2006 | Details |
| A53025 | 17122751 | Panminerva Med | Metabolic syndrome and renal failure: similarities and differences. | 2006 | Details |
| A53026 | 17111296 | Horm Metab Res | Macroangiopathy in adults and children with diabetes: from molecular mechanisms to vascular damage (part 1). | 2006 | Details |
| A53027 | 17106922 | World J Gastroenterol | Mechanisms and significance of liver steatosis in hepatitis C virus infection. | 2006 | Details |
| A53028 | 17077342 | Am J Physiol Endocrinol Metab | Glucocorticoids produce whole body insulin resistance with changes in cardiac metabolism. | 2006 | Details |
| A53029 | 17016629 | Int J Mol Med | Hemostasis alterations in metabolic syndrome (review). | 2006 | Details |
| A53032 | 16956601 | Clin Chim Acta | Molecular mechanisms of insulin resistance and associated diseases. | 2006 | Details |
| A53034 | 16903166 | Clin Cornerstone | Atherogenic dyslipidemia associated with metabolic syndrome and insulin resistance. | 2006 | Details |
| A53035 | 16877964 | J Hypertens | Irbesartan restores the in-vivo insulin signaling pathway leading to Akt activation in obese Zucker rats. | 2006 | Details |
| A53036 | 16778573 | Curr Opin Clin Nutr Metab Care | Metabolic consequences of lipodystrophy in mouse models. | 2006 | Details |
| A53039 | 16750656 | Vascul Pharmacol | Adverse hepatic and cardiac responses to rosiglitazone in a new mouse model of type 2 diabetes: relation to dysregulated phosphatidylcholine metabolism. | 2006 | Details |
| A53043 | 16669279 | MMW Fortschr Med | [Secondary dyslipoproteinema in liver disease]. | 2006 | Details |
| A53044 | 16598526 | Clin Res Cardiol | Gender differences in the metabolic syndrome and their role for cardiovascular disease. | 2006 | Details |
| A53046 | 16557184 | Minerva Gastroenterol Dietol | Steatosis, insulin resistance and fibrosis progression in chronic hepatitis C. | 2006 | Details |
| A53047 | 16516330 | J Hepatol | Gallbladder disease is associated with insulin resistance in a high risk Hispanic population. | 2006 | Details |
| A53049 | 16478779 | Am J Physiol Endocrinol Metab | Elevated resistin levels in cirrhosis are associated with the proinflammatory state and altered hepatic glucose metabolism but not with insulin resistance. | 2006 | Details |
| A53050 | 16477380 | Mol Cell Biochem | Peroxisome proliferator-activated receptor-alpha selective ligand reduces adiposity, improves insulin sensitivity and inhibits atherosclerosis in LDL receptor-deficient mice. | 2006 | Details |
| A53052 | 16446448 | Proc Natl Acad Sci U S A | The metabolic syndrome resulting from a knockout of the NEIL1 DNA glycosylase. | 2006 | Details |
| A53056 | 16253642 | Metabolism | Endothelin antagonism improves hepatic insulin sensitivity associated with insulin signaling in Zucker fatty rats. | 2005 | Details |
| A53057 | 16248830 | Curr Drug Targets Cardiovasc Haematol Disord | Role of PPAR- gamma agonist thiazolidinediones in treatment of pre-diabetic and diabetic individuals: a cardiovascular perspective. | 2005 | Details |
| A53058 | 16225474 | Aliment Pharmacol Ther | Review article: hepatitis C virus-associated steatosis--pathogenic mechanisms and clinical implications. | 2005 | Details |
| A53060 | 16183630 | Am J Physiol Regul Integr Comp Physiol | Tesaglitazar, a dual PPAR{alpha}/{gamma} agonist, ameliorates glucose and lipid intolerance in obese Zucker rats. | 2005 | Details |
| A53061 | 16170675 | Herz | [Metabolic syndrome and hyperlipidemia in HIV-positive patients]. | 2005 | Details |
| A53063 | 16109719 | J Biol Chem | Estrogen regulation of adiposity and fuel partitioning. Evidence of genomic and non-genomic regulation of lipogenic and oxidative pathways. | 2005 | Details |
| A53064 | 16088969 | Diabetes Metab Res Rev | Prevention of nutritionally induced diabetes by rosiglitazone in the gerbil Psammomys obesus. | 2006 | Details |
| A53066 | 15962320 | Hepatology | Steatosis: co-factor in other liver diseases. | 2005 | Details |
| A53067 | 15817811 | Am J Physiol Gastrointest Liver Physiol | Acute hepatic steatosis in mice by blocking beta-oxidation does not reduce insulin sensitivity of very-low-density lipoprotein production. | 2005 | Details |
| A53068 | 15809359 | Hypertension | A new transgenic rat model of hepatic steatosis and the metabolic syndrome. | 2005 | Details |
| A53070 | 15802066 | Obes Surg | Histological changes in the liver of morbidly obese patients: correlation with metabolic parameters. | 2005 | Details |
| A53072 | 15687414 | Obes Res | Pathophysiology and long-term management of the metabolic syndrome. | 2004 | Details |
| A53073 | 15672115 | Int J Obes (Lond) | Childhood obesity and insulin resistance in a Yucatan mini-piglet model: putative roles of IGF-1 and muscle PPARs in adipose tissue activity and development. | 2005 | Details |
| A53075 | 15589689 | Biochimie | Effects of streptozotocin and dietary fructose on delta-6 desaturation in spontaneously hypertensive rat liver. | 2004 | Details |
| A53077 | 15553597 | Nutr Metab Cardiovasc Dis | Insulin sensitivity and hepatic steatosis in obese subjects with normal glucose tolerance. | 2004 | Details |
| A53078 | 15543204 | Lab Invest | Overexpression of fatty acid synthase in chemically and hormonally induced hepatocarcinogenesis of the rat. | 2005 | Details |
| A53084 | 15297448 | Endocrinology | Small-molecule insulin mimetic reduces hyperglycemia and obesity in a nongenetic mouse model of type 2 diabetes. | 2004 | Details |
| A53085 | 15262452 | Clin Ther | A comparison of the effects of thiazolidinediones and metformin on metabolic control in patients with type 2 diabetes mellitus. | 2004 | Details |
| A53086 | 15230153 | Przegl Lek | [Adiponectin--adipocytokine with a broad clinical spectrum]. | 2004 | Details |
| A53087 | 15181027 | J Clin Endocrinol Metab | Medical consequences of obesity. | 2004 | Details |
| A53088 | 15173878 | J Clin Invest | The case of visceral fat: argument for the defense. | 2004 | Details |
| A53089 | 15166810 | Curr Opin Lipidol | Pathophysiology of dyslipidemia and increased cardiovascular risk in HIV lipodystrophy: a model of 'systemic steatosis'. | 2004 | Details |
| A53090 | 15157941 | J Nutr Biochem | Effects of fish oil on hypertension, plasma lipids, and tumor necrosis factor-alpha in rats with sucrose-induced metabolic syndrome. | 2004 | Details |
| A53091 | 15090211 | Assay Drug Dev Technol | A self-contained 48-well fatty acid oxidation assay. | 2004 | Details |
| A53092 | 15083594 | Curr Opin Investig Drugs | Acetyl-CoA carboxylase inhibition for the treatment of metabolic syndrome. | 2004 | Details |
| A53093 | 15083407 | Dtsch Med Wochenschr | [Reduced insulin effect in subclinical fatty liver]. | 2004 | Details |
| A53096 | 15010338 | Am J Physiol Endocrinol Metab | Elevated circulating adiponectin levels in liver cirrhosis are associated with reduced liver function and altered hepatic hemodynamics. | 2004 | Details |
| A53098 | 14739074 | Biochimie | Central role of the adipocyte in the insulin-sensitising and cardiovascular risk modifying actions of the thiazolidinediones. | 2003 | Details |
| A53099 | 14728015 | Am J Cardiovasc Drugs | Drug treatment of combined hyperlipidemia. | 2001 | Details |
| A53100 | 14717339 | Hypertens Res | Effects of radiation on fatty liver and metabolic coronary risk factors among atomic bomb survivors in Nagasaki. | 2003 | Details |
| A53102 | 14642624 | J Hepatol | In overweight patients with chronic hepatitis C, circulating insulin is associated with hepatic fibrosis: implications for therapy. | 2003 | Details |
| A53103 | 14577612 | Mol Cell Biochem | Effects of niacin-bound chromium, Maitake mushroom fraction SX and (-)-hydroxycitric acid on the metabolic syndrome in aged diabetic Zucker fatty rats. | 2003 | Details |
| A53107 | 12930161 | Drugs | Metformin: new understandings, new uses. | 2003 | Details |
| A53110 | 12793594 | Int J Clin Pract Suppl | The relationship of obesity to the metabolic syndrome. | 2003 | Details |
| A53112 | 12733392 | Presse Med | [From hepatic steatosis due to obesity to cirrhosis, in the absence of alcoholic intoxication]. | 2003 | Details |
| A53114 | 12660870 | Horm Metab Res | Depot-specific hormonal characteristics of subcutaneous and visceral adipose tissue and their relation to the metabolic syndrome. | 2003 | Details |
| A53118 | 12401884 | J Lipid Res | AZ 242, a novel PPARalpha/gamma agonist with beneficial effects on insulin resistance and carbohydrate and lipid metabolism in ob/ob mice and obese Zucker rats. | 2002 | Details |
| A53120 | 12163688 | J Nutr | The effects of diet, genetics and chemicals on toxicity and aberrant DNA methylation: an introduction. | 2002 | Details |
| A53122 | 12015640 | Klin Padiatr | [Lipodystrophies]. | 2002 | Details |
| A53123 | 11921433 | Diabetes Metab Res Rev | The mode of action of thiazolidinediones. | 2002 | Details |
| A53124 | 11921432 | Diabetes Metab Res Rev | Insulin resistance in type 2 diabetes: role of fatty acids. | 2002 | Details |
| A53126 | 11832699 | J Acquir Immune Defic Syndr | Long-term exposure to lifelong therapies. | 2002 | Details |
| A53128 | 11729749 | Adv Anat Embryol Cell Biol | Cooperation of liver cells in health and disease. | 2001 | Details |